Recolony gets featured by Handelzeitung
Philipp Busenhart, CBO of Recolony, presents our company in this interview with the Handelzeitung
top of page
Newsroom
Learn more about Recolony bacteria-based cancer therapy, plus never miss an event.
Feb 23, 20231 min read
Recolony receives CHF 150,000 from Venture Kick
Recolony wins the Stage III of Venture Kick. Recolony will invest the CHF 150,000 awarded by Venture Kick to advance our small molecule...
1790
Sep 14, 20221 min read
SWICA interviews Recolony
SWICA September Newsletter includes an article about Recolony Source: Swiss.ch
610
Apr 21, 20221 min read
Our CEO is highlighted in the UZH Annual Report 2021
Ana Montalban-Arques got interviewed by the University of Zurich to talk about our bacteria-based cancer therapy for the treatment of...
660
Feb 11, 20221 min read
Our CEO wins a young women scientist award
Our CEO Ana Montalban-Arques is awarded with one of the Lyceum Awards to young women scientists in the category of Health Sciences. She...
450
Jan 25, 20221 min read
Werner Siemens Stiftung interviews Ana Montalban-Arques
Within the section "From lab to market" of the Werner Siemens Stiftung annual report 2021, our CEO Ana Montalban-Arques explains the...
280
Oct 15, 20211 min read
Our research gets featured in Cell Reports Medicine.
Our article "Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors" is highlighted in the...
560
bottom of page